Login / Signup

Risk-benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19.

Sivaraman DhanasekaranLeela Kagithakara VajraveluVenugopal Venkatesalu
Published in: Postgraduate medical journal (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • bone marrow
  • respiratory syndrome coronavirus
  • replacement therapy